Regenicin, Inc. (OTCPK:RGIN) announced that it has entered into a securities purchase agreement for private placement of 1 convertible promissory note for gross proceeds of $25,000 in May 2013. The transaction included participation from individual investor. The note will be convertible into common shares at a fixed conversion price of $0.05 per share.

The note will carry an interest rate of 8% per annum and would mature in November 2013.